SB
SightStream Biotherapeutics, Inc.
SEC filingBiotechnology · Walpole, MA
Amount raised$1.8Msold at filing
Total offering$1.8M
Investors in the raise9count reported to the SEC
FiledOct 16, 2025first sale Oct 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Samuel WuDirector
Wenkai XiangDirector
David NeafusExecutive Officer
Reza DanaDirector
Jason WernerExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.